Mahindra Lifespace

Mahindra Lifespace: OMRON Healthcare to set up factory in Mahindra Lifespaces' industrial park in Chennai for blood pressure monitors (BPMs). OMRON is the Global No. 1 brand in digital BPM devices with over 200 Mn home BPMs sold worldwide.

Biocon

Biocon: USFDA has concluded a Surveillance and Pre-Approval Inspection of Biocon's Oral Solid Dosage Formulations Manufacturing facility with No Observations

Wonderla Holidays

Wonderla Holidays: The Tamil Nadu government has granted a waiver of local body tax (LBT) of 10 percent to its Chennai project for 10 years from the commencement of commercial operations. This is subject to the condition that the commercial operation shall commence within two years from June 2.

IIFL Finance:

IIFL Finance: The board has approved Tranche II public issue of non-convertible debentures of Rs 300 crore with a green-shoe option of up to Rs 1,200 crore. This is within the shelf limit of Rs 5,000 crore. The issue will open on June 9 and close June 22.

Lupin:

Lupin: The pharma major has launched Darunavir tablets, in 600 mg and 800 mg strength, to market a generic equivalent of Prezista tablets of Janssen Products, LP, which reduces the amount of HIV in the blood. Darunavir tablets had estimated annual sales of $308 million in the US, as per IQVIA MAT March 2023.

Indian Overseas Bank:

Indian Overseas Bank: The Reserve Bank of India (RBI) has imposed a penalty of Rs 2.20 crore on Indian Overseas Bank for deficiencies in regulatory compliance.

Zydus Lifesciences

Zydus Lifesciences: The US Food and Drug Administration (USFDA) has closed the inspection of the company's animal health drug manufacturing facility in Ahmedabad, with nil observations. The USFDA inspected the plant from May 30 to June 2.